Asthma-Cases.com:

Home >
Faculty >
Webcasts >
Publications >
Links to EPR-3 Reports >
Contact Us >

Expired Although this activity is no longer certified for credit, we believe that it contains important information and hope you'll review, print or email it to a colleague.

Managing Asthma in Primary Care: Understanding and Implementing the US Guidelines

Click here to download the publication?

Target Audience

This activity has been designed to meet the educational needs of primary care physicians interested in the diagnosis and management of asthma.

Educational Objectives

After completing this activity, participants should be better able to:

• Articulate the current pathophysiologic concept of asthma and how it informs patient diagnosis, assessment, and management.
• Apply the concepts of severity and control as described in the most recent Expert Panel Report (EPR-3) to patient diagnosis, assessment, and follow-up.
• Prioritize integration of education, written asthma action plans, and self management into patient care.
• Apply the concept of asthma’s heterogeneity to practice by individualizing treatment based on factors such as patient symptoms, precipitating factors, comorbid conditions, adherence, and goals.
• Educate patients about the link between risk of death and use of, inhaled corticosteroids and short-acting ß-agonists to motivate adherence to long-term control therapy.

Instructions for Participation

To receive a CME certification of participation, participants should:

• Read the entire publication, including the Continuing Medical Education Information.
• Complete the posttest questions and evaluation form on pages 15 and 16 and mail or fax the evaluation form with answer key to Paradigm Medical Communications, LLC, 523 Route 303, Orangeburg, NY 10962; Fax: 845-398-5108.

A certificate of participation will be issued 4 to 6 weeks after receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

Accreditation and Credit Designation

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Sepracor.

This educational activity is sponsored by Paradigm Medical Communications, LLC, Orangeburg, NY.

Release date: April 1, 2011
Last review date: February 7, 2011
Expiration date: March 31, 2012
Estimated time to complete activity: 1.5 hours.

Contributing Faculty and Disclosures

In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in this activity

Eli O. Meltzer, MD
Clinical Professor
Department of Pediatrics
Division of Allergy and Immunology
University of California, San Diego
San Diego, CA
Grant/Research Support: Alcon, Amgen, Apotex, AstraZeneca, Boehringer Ingelheim, Capnia, Genentech, GlaxoSmithKline, MAP Pharmaceuticals, Meda, Merck, Novartis, Pharmaxis, Sanofi-Aventis, Schering-Plough, Sepracor, Skye Pharma, Teva, Vocel, Wyeth.
Consultant/Speaker: Abbott, Alcon, Amgen, AstraZeneca, Capnia, Dey, Evolutec, Genentech, GlaxoSmithKline, Greer, Inspire, Johnson & Johnson, Meda, Merck, Novartis,Pfizer, Sanofi-Aventis, Schering-Plough, Sepracor, Shionogi, VentiRx, Wyeth.

Matthew Mintz, MD, FACP
Associate Professor of Medicine
Division of Medicine
The George Washington School of Medicine
Washington, DC
Consultant/Speaker: AstraZeneca, GlaxoSmithKline, Sepracor, Takeda.

William P. Hitchcock, MD, FAAP
Assistant Clinical Professor
Department of Pediatrics
University of California San Diego School of Medicine
San Diego, CA
Consultant/Speaker: AstraZeneca, GlaxoSmithKline, Merck, MedImmune, Sanofi-Pasteur, Sepracor.

Independent peer reviewers
No financial relationships to disclose

No Paradigm Medical Communications staff member who was in a position to control or influence the content of this educational activity has a conflict of interest.

Eileen McCaffrey, Consulting Editor
No financial relationships to disclose

Christie Wilson, Designer
No financial relationships to disclose

Resolution of Conflict of Interest

Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each continuing medical education activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes, including peer-review, as in this case.